-
101
Diversity of hydrozoans on artificial substrates in large commercial ports of the Sea of Marmara
Published 2024-12-01Get full text
Article -
102
Intrauterine Growth Restriction: Effects of Physiological Fetal Growth Determinants on Diagnosis
Published 2013-01-01Get full text
Article -
103
Flow and Transport in Tight and Shale Formations: A Review
Published 2017-01-01Get full text
Article -
104
-
105
-
106
Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions
Published 2025-01-01Get full text
Article -
107
Lipid Antigens: Revealing the Hidden Players in Adaptive Immune Responses
Published 2025-01-01Get full text
Article -
108
-
109
-
110
-
111
-
112
-
113
-
114
Inaugural Lecture
Published 2023“…He took research residence at University of Antwerp (Belgium), CMI Bergen, University of Bergen, Norway, Steamboat Springs, Colorado US, and Chinese Academy of Social Sciences (CASS) in Beijing. …”
Get full text
Other -
115
Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data St...
Published 2025-01-01“…Katarina Puco,1 Cathrine S Notland,2 Robert Szulkin,3,4 Christian Jonasson,5 Christian Beisland,6,7 Tom B Johannesen,8 Oddvar Solli,9 Jan Oldenburg,10,11 Daniel Heinrich12 1Department of Oncology, Hematology and Palliative Care, Lovisenberg Diaconal Hospital, Oslo, Norway; 2Department of Medical Affairs, Pfizer AS, Oslo, Norway; 3SDS Life Science, Stockholm, Sweden; 4Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Solna, Sweden; 5Department of Public Health and Nursing, Faculty of Medicine and Health Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; 6Department of Urology, Haukeland University Hospital, Bergen, Norway; 7Department of Clinical Medicine, University of Bergen, Bergen, Norway; 8Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway; 9Health and Value, Pfizer AS, Oslo, Norway; 10Department of Oncology, Akershus University Hospital HF, Lørenskog, Norway; 11Faculty of Medicine, University of Oslo, Oslo, Norway; 12Department of Radiotherapy and Oncology, Innlandet Hospital Trust HF, Division Gjøvik/Lillehammer, NorwayCorrespondence: Katarina Puco, Department of Oncology, Hematology and Palliative Care, Lovisenberg Diaconal Hospital, Oslo, Norway, Tel +47 416 86 298, Email katarina.puco@lds.noPurpose: In Norway, 5-year survival rates of patients with renal cell carcinoma (RCC) are increasing. …”
Get full text
Article -
116
-
117
From Cure to Crisis: Understanding the Evolution of Antibiotic-Resistant Bacteria in Human Microbiota
Published 2025-01-01Get full text
Article -
118
The Growth and Decay of Intense GNSS Amplitude and Phase Scintillation During Non‐Storm Conditions
Published 2024-12-01Get full text
Article -
119
-
120